Literature DB >> 21785365

CD4⁺CD25⁺Foxp3⁺ regulatory T cells suppress cardiac fibrosis in the hypertensive heart.

Peter Kanellakis1, Tam N Dinh, Alex Agrotis, Alexander Bobik.   

Abstract

BACKGROUND: CD4⁺CD25⁺Foxp3⁺ regulatory T cells (Tregs) are potent inhibitors of inflammation and autoimmune diseases. Because inflammation has been associated with development of cardiac fibrosis in experimental hypertension, here we investigated whether adoptively transferred Tregs would inhibit development of cardiac fibrosis initiated by elevating blood pressure.
METHODS: Cardiac fibrosis was induced in mice by constricting the aorta between the two carotid arteries. Immediately after the operation mice received either vehicle or purified, cultured Tregs (1.5 × 10⁶). Fourteen days later we assessed effects on developing left ventricular fibrosis, blood pressure, inflammation, myofibroblasts and the transforming growth factor-beta1 (TGF-β1) system.
RESULTS: Fourteen days after aortic constriction, marked left-ventricular fibrosis was apparent and this was greatly reduced in mice receiving adoptively transferred Tregs. This reduction in fibrosis was associated with attenuated inflammatory cell numbers, reduced interstitial myofibroblast numbers and attenuated activity of the TGF-β1 system, indicated by reductions in the expression of TGF-β1 and its receptors activin-like kinase-5 and type II TGF-β receptor. Adoptively transferred Tregs did not affect blood pressure and exerted only a small effect on left-ventricular hypertrophy.
CONCLUSIONS: These data indicate that Tregs attenuate cardiac fibrosis associated with hypertensive heart disease by suppressing inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785365     DOI: 10.1097/HJH.0b013e328349c62d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  30 in total

Review 1.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 2.  Tissue Tregs.

Authors:  Marisella Panduro; Christophe Benoist; Diane Mathis
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

Review 3.  Inflammation and hypertension: new understandings and potential therapeutic targets.

Authors:  Carmen De Miguel; Nathan P Rudemiller; Justine M Abais; David L Mattson
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

4.  Mesh induced fibrosis: The protective role of T regulatory cells.

Authors:  Amanda M Artsen; Matthew Rytel; Rui Liang; Gabrielle E King; Leslie Meyn; Steven D Abramowitch; Pamela A Moalli
Journal:  Acta Biomater       Date:  2019-07-19       Impact factor: 8.947

Review 5.  Role of Platelet-Derived Transforming Growth Factor-β1 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis.

Authors:  Jasimuddin Ahamed; Jeffrey Laurence
Journal:  Antioxid Redox Signal       Date:  2017-07-05       Impact factor: 8.401

Review 6.  T-cell involvement in sex differences in blood pressure control.

Authors:  G Ryan Crislip; Jennifer C Sullivan
Journal:  Clin Sci (Lond)       Date:  2016-05-01       Impact factor: 6.124

7.  CD4+CD25+Foxp3+ regulatory T cells contribute in liver fibrosis improvement with interferon alpha.

Authors:  L Feng; H Kang; L N Liu; Y M Cao
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 8.  Regulatory T cells in cardiovascular diseases.

Authors:  Xiao Meng; Jianmin Yang; Mei Dong; Kai Zhang; Eric Tu; Qi Gao; Wanjun Chen; Cheng Zhang; Yun Zhang
Journal:  Nat Rev Cardiol       Date:  2015-11-03       Impact factor: 32.419

Review 9.  Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.

Authors:  Michele Cavalera; Junhong Wang; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2014-05-10       Impact factor: 7.012

Review 10.  The pathogenesis of cardiac fibrosis.

Authors:  Ping Kong; Panagiota Christia; Nikolaos G Frangogiannis
Journal:  Cell Mol Life Sci       Date:  2013-05-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.